Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciad478 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Richard N Olans und 1 weiteren Autor:innen. Beteiligte Einrichtung: Tufts Medicine, Melrose-Wakefield Hospital, Melrose, Massachusetts, USA. Hauptthemen laut MEDLINE: Drug Hypersensitivity, Hypersensitivity. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Tufts Medicine, Melrose-Wakefield Hospital, Melrose, Massachusetts, USA.
- MGH Institute of Health Professions, Boston, Massachusetts, USA.
ORCID-Profile: Richard N Olans, Rita Drummond Olans
Zitieren
APA
Olans, R. N., & Olans, R. D. (2024). Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad478
Vancouver
Olans RN, Olans RD. Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad478
BibTeX
@article{Olans2024,
author = {Olans, Richard N and Olans, Rita Drummond},
title = {Linking the Who, What, When, and Where of Inpatient Direct Oral Penicillin Challenge With the How of Durable Penicillin Allergy Delabeling},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciad478}
}
EUVIMED